Quotient Therapeutics

Quotient Therapeutics is a biotechnology company founded in 2022 by Flagship Pioneering. It's focused on pioneering a new field of genetics called somatic genomics, which studies the genetic variation within the trillions of cells in our bodies. They believe this approach holds the key to unlocking novel links between genes and disease, enabling the discovery of transformative medicines.

Quotient's Somatic Genomics platform utilizes single-molecule genome sequencing technology to identify somatic mutations that drive disease at an unprecedented level of resolution. This platform is used to identify and validate genes, proteins, and pathways that can serve as targets for the development of novel therapeutics. Quotient's work has the potential to revolutionize drug discovery and development across a broad range of therapeutic areas, including oncology, neurodegenerative disease, and immune disorders.

Quotient Therapeutics does not specify the type of work arrangements or job flexibility offered in their job postings or company website. NONE

Quotient Therapeutics is a biotechnology company pioneering the use of somatic genomics to develop transformative medicines. By studying the genetic variation and evolution of the trillions of cells within the human body, Quotient aims to uncover novel links between genes and disease, leading to the development of therapies that cure, prevent, or reverse a wide range of diseases. Their Somatic Genomics platform leverages proprietary single-molecule genome sequencing technology and data analysis to identify naturally selected genes, proteins, and pathways as potential drug targets. Quotient is driven by the belief that understanding the natural genetics library inside every tissue holds the key to unlocking the medicines of tomorrow.

Quotient Therapeutics fosters a culture of curiosity, collaboration, and data-driven innovation. They value experimentation, taking risks, and adapting quickly to new information, while maintaining a strong sense of community and respect for each individual. This is reflected in their open communication style, cross-functional teamwork, and focus on providing opportunities for personal and professional growth.

Quotient Therapeutics values diversity, equity, and inclusion as core principles to fuel its innovative approach to drug discovery. They actively seek to build a diverse and inclusive team, recognizing that different perspectives and experiences enhance scientific discovery. Their commitment to fostering a culture of respect and collaboration is evident in their diverse leadership team and efforts to create an equitable workplace where all employees feel valued and empowered to contribute their unique skills and ideas.